BioNTech SE Total Assets Growth & History (BNTX)
BioNTech SE's total assets was €21.99B for fiscal 2025.
View full BioNTech SE company overviewBioNTech SE annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €21.99B | −€541.1M | −2.40% |
| 2024 | 2024-12-31 | €22.53B | −€476.6M | −2.07% |
| 2023 | 2023-12-31 | €23.01B | −€272.8M | −1.17% |
| 2022 | 2022-12-31 | €23.28B | €7.45B | +47.05% |
| 2021 | 2021-12-31 | €15.83B | €13.51B | +582.77% |
| 2020 | 2020-12-31 | €2.32B | €1.52B | +190.68% |
| 2019 | 2019-12-31 | €797.6M | €144.7M | +22.15% |
| 2018 | 2018-12-31 | €653.0M | — | — |
BioNTech SE quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €20.34B | −€1.29B | −5.98% |
| Q1 2026 | 2026-03-31 | €21.07B | — | — |
| Q4 2025 | 2025-12-31 | €21.99B | −€541.1M | −2.40% |
| Q3 2025 | 2025-09-30 | €21.34B | — | — |
| Q2 2025 | 2025-06-30 | €21.64B | — | — |
| Q4 2024 | 2024-12-31 | €22.53B | −€476.6M | −2.07% |
| Q4 2023 | 2023-12-31 | €23.01B | −€272.8M | −1.17% |
| Q4 2022 | 2022-12-31 | €23.28B | €7.45B | +47.05% |
| Q4 2021 | 2021-12-31 | €15.83B | €13.51B | +582.77% |
| Q4 2020 | 2020-12-31 | €2.32B | €1.52B | +190.68% |
| Q4 2019 | 2019-12-31 | €797.6M | €144.7M | +22.15% |
| Q4 2018 | 2018-12-31 | €653.0M | — | — |
BioNTech SE total assets trends
Over the last five fiscal years, BioNTech SE's total assets increased from €2.32B to €21.99B, a change of €19.67B. The latest reported quarter, Q2 2026, shows €20.34B.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioNTech SE source filings ↗